What happened
HEM Pharma disclosed convertible bonds to raise US$38M, about 22.4% of its market value.
For context, this raise equals about 22.4% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$38M |
| vs. market value | 22.4% |
| Filed | 2026-08-06, Material event report (convertible bonds) |
| Source | DART rcept 20260806000534 → open original filing |
Source: DART. Information only, not investment advice.